Nuclear reprogramming is the name given to the change that occurs in the nucleus of a somatic cell when it is induced to revert from its differentiated state and assumes a pluripotent state, from which it can adopt any cellular identity, given the appropriate cues. This is the basis for much of the promise in regenerative medicine, for example in the repopulation of bone marrow follow ing chemotherapy. In a laboratory setting, repro gram ming can be achieved in two ways. In the first, the somatic cell nucleus is transferred into an oocyte. Here the oocyte provides the necessary factors to reprogram the somatic nucleus, which is in principle then capable of recapitulating the entire developmental program. In the second, expression of four key transcription factors (Oct4, Sox2, Klf4 and cMyc) is sufficient to reprogram a somatic cell to produce what is known as an induced pluripotent stem cell (iPSC) state, originally discovered by Shinya Yamanaka and colleagues [1] .
therapeutic uses, is particularly inefficient because donor cells from these tissues are at a late stage of differentiation [2] . It also appears that iPSCs are not truly equivalent to the pluripotent embryonic stem cell, as iPSCs display a reduced differentiation capacity that is biased to the cell lineage of origin. This is consistent with the observation that iPSCs may retain a memory of the somatic cell gene expression pattern. An important aim of research in this field, therefore, is a better understanding of the mecha nism of reprogramming that may lead to improvements in the efficiency and fidelity with which pluripotent stems cells can be generated. Such an understanding is begin ning to emerge from studies on chromatin remodeling in the generation of pluripotent stem cells.
Resetting the chromatin landscape
Studies on iPSC generation have suggested that chroma tin at the promoters and enhancers of pluripotency genes in somatic cells is in a repressed state characterized by modifications such as DNA methylation and histone deacetylation, and this is a roadblock to reprogramming, which is thus promoted by inhibitors of DNA methylation and histone deacetylation [3] . cMyc is thought to function as a catalyst in this process, by increasing the rate of cell proliferation and perhaps transcriptional elongation, both of which result in largescale chromatin remodeling.
In the study reported in Epigenetics & Chromatin, John Gurdon and colleagues describe the investigation of reprogramming that is independent of DNA replication, by transferring mammalian somatic cell nuclei into Xenopus oocytes, which are mitotically arrested, and following the resulting chromatin changes [4] . They focused on the incorporation of the histone variant H3.3, which is a hallmark of sites of high nucleosome turnover, and is associated with active genes and their regulatory elements [5, 6] . When they microinjected mRNA encod ing epitopetagged H3.3 into the oocytes prior to nuclear transfer, they observed early incorporation of H3.3 into the pluripotency gene Oct4 coincident with the onset of Abstract A half century after John Gurdon demonstrated nuclear reprogramming, for which he was awarded the 2012 Nobel Prize in Physiology or Medicine, his group provides insights into the molecular mechanisms whereby chromatin remodeling is required for nuclear reprogramming. Among the issues addressed in Gurdon's latest work are the chromatin impediments to artificially induced reprogramming, discovered by Shinya Yamanaka, who shared the award with Gurdon.
transcription of the gene. To check the requirement for H3.3, they injected into the oocyte polyclonal antibodies against HIRA, the chaperone responsible for the incor poration of histone H3.3 into chromatin, and were able to show that this abrogates transcriptional reprogramming. They also showed, by the use of the polymerase II inhibitor alphaamanitin, that H3.3 incorporation depends on transcriptional activity as well as HIRA. Impaired reprogramming in the absence of HIRA and H3.3 deposition could not be compensated for by the increased deposition of histone variant H3.2. These results imply that some specific function is attributable to the H3.3 deposition pathway in promoting reprogramming, and raises the question of what that function might be.
Reprogramming is far less efficient than differentiation and this may reflect the need for reprogramming factors to overcome changes to the chromatin environment that occur with differentiation. Embryonic stem cells are characterized by a highly dynamic chromatin state compared with that of more differentiated cell types [7] , and pluripotency genes in particular have been shown to gain repressive chromatin marks during differentiation. It is, however, at these silenced sites that the reprogram ming factors must bind to elicit their effects. Whilst cMyc binding occurs early in the reprogramming process, Oct4, Sox2 and to a lesser extent Klf4, which co occupy a large number of promoters, bind only later during reprogramming. Delayed binding of Oct4, Sox2 and Klf4, presumably because of the repressive chromatin environment at their binding sites, is thought to be a major roadblock in the reprogramming process.
As transcription factor binding sites associated with active genes are marked by rapidly turningover nucleo somes, it is probable that during reprogramming the nucleosomes at the Oct4/Sox2/Klf4 sites become re modeled to contain H3.3. The high turnover observed at regulatory sites might be required to prevent sites from becoming stably occupied by nucleosomes, which would impede transcription factor binding and therefore reprogramming. This removal of repressive chromatin and replacement with H3.3 may facilitate transcription factor binding and successful reprogramming. Perhaps, therefore, HIRAdependent H3.3 deposition is function ing to promote pluripotency. This is consistent with the observation that HIRA deficient embryonic stem cells rapidly differentiate [7] . It also, however, raises the ques tion of how histone H3.3 may confer a more accessible chromatin environment.
Histone H3.3: striking a balance
One obvious possibility is that the high turnover of H3.3 containing nucleosomes reflects some intrinsic insta bility. However, H2A/H3.3containing nucleosomes seem to be just as stable in vitro as H2A/H3.1containing nucleosomes [8] . Another possibility is that histone H3.3 accumulates at these high turnover sites as a gapfilling mechanism after the eviction of nucleosomes following transcription or the activity of chromatin remodelers. The observations of Gurdon and colleagues, however, indicate failure of histone variant H3.2 to compensate for the lack of H3.3 deposition, suggesting that there is more to H3.3 deposition in the reprogramming process than simple gap filling.
If there is nothing intrinsic to the amino acid sequence of H3.3 that favors a permissive chromatin state, then perhaps the deposition process itself is key. Perhaps, therefore, a specific posttranslational modification of H3.3 might be associated with HIRAdependent deposi tion, or an additional chromatin remodeling step at the point of H3.3 deposition might promote an active chro matin conformation and accessibility to the underlying DNA sequence. iPSC generation has been suggested to be a stochastic process [9] , which at a molecular level may reflect the stochastic nature of binding by the reprogramming factors to their target sequences due to transient exposure of these sites in the repressive chromatin environment [10] . Increases in the deposition of H3.3 may therefore facilitate reprogramming by increas ing the frequency of exposure of these binding sites (Figure 1a) .
A key question for future studies is whether the over expression of HIRA and/or histone H3.3 may accelerate reprogramming and increase the efficiency of iPSC generation by allowing the remodeling of transcription factor binding sites. A second, related question is whether such overexpression might provide the neces sary replicationindependent chromatin remodeling, thereby reducing the requirement for cMyc as a catalyst. This would be desirable because cMyc, which is thought to aid reprogramming by increasing the rate of cell proliferation and thereby genomewide chromatin remodeling, is a protooncogene; there are thus naturally concerns about its induced expression in the generation of iPSCs as a therapeutic agent.
There is, however, a potential pitfall in the over expression of HIRA/H3.3 in reprogramming. Whilst it may allow the remodeling of repressive chromatin to promote gene activation, histone H3.3 has also been shown in an earlier study by Gurdon and colleagues [11] to potentiate transcriptional memory (Figure 1b) . In that study, using reprogramming via somatic cell nuclear transfer into enucleated Xenopus oocytes, they showed that overexpression of histone H3.3 increased the fre quency at which nuclei maintained their original trans criptional program, as determined by MyoD expression. They have since suggested that the unusually high H3.3 content in eggs is responsible for this trans criptional memory [2] . This may suggest the need for a delicate balance in the overexpression of HIRA and/or H3.3, in which factor binding will be facilitated through chroma tin decondensation, but transcriptional memory will not be evoked. Given the evidence that trans crip tional memory in iPSCs may cause some of the observed limitations to the regenerative applications of these cells, clearly the operation of the H3.3 pathway in both re programming and memory will need to be taken into account in any manipulation of that pathway for thera peutic purposes. Gurdon's latest work thus forges a connection, through the changes to chromatin required for reprogramming, between the two 2012 Nobel Prize winning papers published almost a half century apart. 
